Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M338Revenue $M19.2Net Margin (%)-367.0Altman Z-Score-1.3
Enterprise Value $M300EPS $-1.4Operating Margin %-333.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-5.9Pre-tax Margin (%)-367.0Higher ROA y-yY
Price/Book9.610-y EBITDA Growth Rate %--Quick Ratio3.5Cash flow > EarningsY
Price/Sales17.25-y EBITDA Growth Rate %--Current Ratio3.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-76.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-137.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M52.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with BDSI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BDSIJulian Robertson 2015-06-30 Sold Out -0.9%$7.26 - $10.5
($8.62)
$ 6.44-25%Sold Out0
BDSIJulian Robertson 2013-12-31 Buy 0.92%$4.24 - $5.98
($5.13)
$ 6.4426%New holding510,874
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BDSI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BDSI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
De Paolantonio Ernest RobertCFO, Secretary and Treasurer 2015-08-26Buy1,650$6.28.87view
STONE WILLIAM BDirector 2015-08-13Sell11,500$7.01-3.71view
ODONNELL FRANCIS E JRDirector 2015-06-16Sell21,597$8.03-15.94view
Sirgo Mark APresident and CEO 2015-06-16Sell4,187$7.97-15.31view
ODONNELL FRANCIS E JRDirector 2015-06-16Sell50,000$8.03-15.94view
Feinberg Barry IDirector 2015-05-26Buy2,000$7.84-13.9view
Feinberg Barry IDirector 2015-05-14Buy2,000$8.54-20.96view
D'Alonzo ThomasDirector 2015-05-13Buy6,226$8.07-16.36view
Sirgo Mark APresident and CEO 2015-02-25Sell94,000$14.25-52.63view
De Paolantonio Ernest RobertCFO, Secretary and Treasurer 2015-02-25Sell3,050$14.44-53.25view

Quarterly/Annual Reports about BDSI:

    News about BDSI:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Vringo Inc, Medivation Inc, BioDelivery Sciences International Inc and H Feb 02 2014 
    comment on BDSI Mar 02 2013 
    comment on BDSI Jan 03 2013 
    comment on BDSI Jan 01 2013 
    comment on BDSI Nov 13 2012 
    Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX Jul 17 2012 
    BioDelivery Sciences International Inc. Reports Operating Results (10-K/A) Nov 19 2010 
    BioDelivery Sciences International Inc. Reports Operating Results (10-Q) Aug 09 2010 
    BioDelivery Sciences International Inc. Reports Operating Results (10-Q) Aug 09 2010 
    BioDelivery Sciences International Inc. (BDSI) CEO Mark A Sirgo buys 4,022 Shares Jun 10 2010 

    More From Other Websites
    BIODELIVERY SCIENCES INTERNATIONAL INC Financials Aug 21 2015
    Analysts Bullish on BioDelivery Ahead of FDA Event Aug 18 2015
    BioDelivery's New Onsolis Formulation Gains FDA Approval Aug 14 2015
    10-Q for BioDelivery Sciences International, Inc. Aug 13 2015
    BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and... Aug 13 2015
    With FDA approval, Raleigh's BioDelivery sees 10% stock bounce Aug 13 2015
    BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS® (fentanyl buccal soluble... Aug 13 2015
    BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS® (fentanyl buccal soluble... Aug 13 2015
    BioDelivery Sciences Strengthens Sales Force Leadership with Hiring of Scott Plesha, Former Salix... Aug 12 2015
    BioDelivery Sciences Strengthens Sales Force Leadership with Hiring of Scott Plesha, Former Salix... Aug 12 2015
    Saia, Werner Enterprises Among New Stakes in Chuck Royce's Portfolio Aug 11 2015
    BioDelivery Incurs Wider Loss in Q2, Revenues Fall Y/Y - Analyst Blog Aug 11 2015
    BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and... Aug 10 2015
    BioDelivery CEO: 'Greater than anticipated challenges' contribute to low drug sales Aug 10 2015
    Edited Transcript of BDSI earnings conference call or presentation 10-Aug-15 12:00pm GMT Aug 10 2015
    BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report Aug 10 2015
    BioDelivery (BDSI) Posts Wider-than-Expected Loss in Q2 - Tale of the Tape Aug 10 2015
    BioDelivery Sciences Provides Corporate Update and Reports Second Quarter 2015 Financial Results Aug 10 2015
    BioDelivery reports 2Q loss Aug 10 2015
    Q2 2015 BioDelivery Sciences International Inc Earnings Release - Before Market Open Aug 10 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK